What should be done for a patient with a history of Attention Deficit Hyperactivity Disorder (ADHD) and depression, who recently started taking Wellbutrin (bupropion) and is now experiencing seizure-like activity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Discontinuation of Wellbutrin Required

Discontinue bupropion (Wellbutrin) immediately and permanently if seizure-like activity has occurred—this is an absolute contraindication to continued use. 1

Immediate Management Steps

Stop the medication now. The FDA drug label explicitly states: "Discontinue bupropion hydrochloride extended-release tablets (XL) and do not restart treatment if the patient experiences a seizure." 1 This is not negotiable—bupropion lowers seizure threshold through its effects on dopaminergic, adrenergic, and nicotinic acetylcholinergic receptor systems. 2

Critical Actions Within 24-48 Hours

  • Obtain emergency neurological evaluation to confirm whether true seizure activity occurred versus other neuropsychiatric symptoms (agitation, tremor, myoclonus). 1, 3
  • Order baseline EEG if seizure is confirmed, as bupropion-induced seizures can show EEG abnormalities that typically resolve within 2-4 weeks. 4, 3
  • Review complete medication list for other seizure threshold-lowering agents (antipsychotics, tricyclic antidepressants, theophylline, systemic corticosteroids, other stimulants). 1
  • Assess for recent discontinuation of alcohol, benzodiazepines (including alprazolam), barbiturates, or antiepileptic drugs, as abrupt withdrawal increases seizure risk with bupropion. 1, 5

Why This Seizure Occurred

The seizure risk with bupropion is dose-dependent, with approximately 0.1% incidence at 300 mg/day, but this can occur even at therapeutic doses in patients without predisposing factors. 1, 4 Your patient experienced this despite presumably being on standard dosing—this represents an idiosyncratic reaction that makes future use absolutely contraindicated. 1

Common pitfall: Seizures can occur even in patients with no personal or family history of seizure disorders, normal neurological examination, and at modest blood levels (as low as 83 ng/mL documented). 4, 5 The case literature shows seizures occurring 4 days to 6 months after starting bupropion. 5, 6

Alternative Treatment for ADHD and Depression

For Depression Management

Switch to an SSRI (sertraline, escitalopram, or fluoxetine) as first-line monotherapy. 7 These have equivalent efficacy to bupropion for major depressive disorder (42-49% remission rates) without seizure risk. 7

  • Start sertraline 50 mg daily or escitalopram 10 mg daily, titrating based on response over 6-8 weeks. 7
  • SSRIs have higher rates of sexual dysfunction compared to bupropion, but this is preferable to seizure risk. 7
  • Monitor for suicidal ideation closely in the first 1-2 weeks, especially if patient is under 24 years old. 7, 1

For ADHD Management

Initiate stimulant medication (methylphenidate or amphetamine) as first-line treatment. 8 Bupropion is not FDA-approved for ADHD and should never be restarted after seizure. 1

  • Methylphenidate starting dose: Begin with immediate-release 5 mg twice daily, titrating by 5-10 mg weekly based on response. 8
  • Monitor for tic exacerbation (though controlled studies show MPH doesn't worsen tics in most patients). 8
  • If seizure disorder develops: Stabilize on antiepileptic drugs first before considering stimulants, as high-dose methylphenidate can cause seizures in adults. 8

Alternative non-stimulant option: Atomoxetine 40 mg daily, titrating to 60-80 mg daily over 7-14 days (maximum 100 mg/day or 1.4 mg/kg/day). 8 This has no seizure risk and addresses both ADHD and depressive symptoms. 8

Monitoring and Follow-Up

  • Neurology consultation required if this was a confirmed seizure to determine if antiepileptic drugs are needed. 9
  • Repeat EEG in 2-4 weeks if initial EEG was abnormal, as bupropion-induced EEG changes typically resolve within this timeframe. 4
  • Do not attempt medication withdrawal of any antiepileptic drugs started until seizure-free for at least 2 years. 9
  • Counsel patient that bupropion in any formulation (immediate-release, SR, XL, or combination products like naltrexone-bupropion) is permanently contraindicated. 1

Critical Safety Warning

Never restart bupropion. Even if the patient had excellent response for depression or ADHD, the occurrence of seizure-like activity makes all bupropion-containing products absolutely contraindicated for life. 1 This includes ZYBAN (for smoking cessation), WELLBUTRIN (all formulations), APLENZIN, and naltrexone-bupropion combinations. 1

The prognosis is generally excellent—most patients remain seizure-free after bupropion discontinuation without requiring long-term antiepileptic drugs, as documented in follow-up studies showing patients seizure-free 5 years later. 4

References

Guideline

Bupropion Contraindications in Seizure Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epileptic seizures, coma and EEG burst-suppression from suicidal bupropion intoxication.

Epileptic disorders : international epilepsy journal with videotape, 2017

Research

A case of bupropion-induced seizure.

The Journal of nervous and mental disease, 1986

Research

Extended-release bupropion induced grand mal seizures.

The Journal of the American Osteopathic Association, 2007

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.